Trial
NCT04549363
Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Multiple Myeloma
Intervention
Belantamab mafodotin
Why stopped
The study has been terminated for reasons pertaining to feasibility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-13